ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1573693
Integrated proteomics analysis and network pharmacology to elucidate the mechanism of Zhilong Huoxue Tongyu Capsule alleviate hypertensive retinopathy in Ang II infusion mice model
Provisionally accepted- 1Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China
- 3Ineye Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 4Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection with TCM Laboratory, Chengdu, China
- 5Drug Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, China
- 6Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Zhilong Huoxue Tongyu Capsule (ZLHXTY) has been used in clinical treatment of vascular diseases caused by hypertension over twenty years. However, the specific mechanisms by ZLHXTY alleviate hypertensive retinopathy(HR) needs to be further explored.Materials and methods: HR mouse model was established by infusing Ang II via subcutaneously implanted osmotic mini-pumps, followed by oral administration of ZLHXTY (0.35,0.7,1.4g/kg/d) 28 days for treatment. To assess the impacts of ZLHXTY on retinal neurodegeneration and vascular injury, multiple experiments such as OCTA, ERG and HE staining were performed. Subsequently,network pharmacological and 4D-label-free proteomics to clarify the potential targets and mechanisms of ZLHXTY alleviated HR. Finally,Western blot, ELISA, IF, and other techniques were utilized to detect the expression of proteins related to inflammation, oxidative stress, and NLRP3 inflammasome activation. Results:ZLHXTY significantly alleviated retinal dysfunction, increased retinal blood flow,and mitigated pathological changes such as retinal tissues edema in HR mice.Network pharmacology indicated that ZLHXTY might exert anti-inflammatory and anti-oxidative stress effects through targets such as TNF and NF-B.Proteomic analysis showed that the differential proteins between the ZL group and the Ang II group were mainly enriched in the immuneinflammatory response, and the main mechanism of which might be related to the assembly of NLRP3 inflammasome. Subsequent in vivo experiments corroborated that ZLHXTY remarkably attenuated inflammation and oxidative stress damage in retinal tissues. Further experiments demonstrated that ZLHXTY inhibited the NLRP3/Caspase-1/GSDMD signaling pathway and related protein expression. Finally, TEM results also verified that ZLHXTY alleviated pyroptosis in retinal cells.Conclusions: Our results suggest that ZLHXTY by regulating the NLRP3/Caspase-1/GSDMD axis,inhibiting pyroptosis,thereby relieving retinal dysfunction and vascular injury in HR mice.
Keywords: ZhiLong HuoXue TongYu Capsule, Traditional Chinese Medicine, Hypertensive Retinopathy, NLRP3 inflammasome, pyroptosis
Received: 09 Feb 2025; Accepted: 21 Apr 2025.
Copyright: © 2025 Wu, Xie, Xie, Duan and Mazhar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Junguo Duan, Ineye Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
Maryam Mazhar, Drug Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.